James Edward Doyle - 17 Mar 2022 Form 4 Insider Report for EXACT SCIENCES CORP (EXAS)

Role
Director
Signature
/s/ James Edward Doyle by Mark R. Busch, attorney-in-fact
Issuer symbol
EXAS
Transactions as of
17 Mar 2022
Net transactions value
+$165,200
Form type
4
Filing time
18 Mar 2022, 16:24:08 UTC
Previous filing
02 Aug 2021
Next filing
08 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EXAS Common Stock Options Exercise $165,200 +10,000 +34% $16.52* 39,830 17 Mar 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EXAS Stock Option (right to buy) Options Exercise $0 -10,000 -54% $0.000000 8,477 17 Mar 2022 Common Stock 10,000 $16.52 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of Common Stock acquired upon the exercise of options in an exercise-and-hold transaction.
F2 These options vested in full on July 24, 2018.